| Date | Title | | | 05/14/13 | Jack Green Joins Verastem as Chief Financial Officer| CAMBRIDGE, Mass.--(BUSINESS WIRE)--May. 14, 2013--
Verastem, Inc., (NASDAQ: VSTM) focused on discovering and developing
drugs to treat cancer by the targeted killing of cancer stem cells,
announced the appointment of John “Jack” Green as Chief Financial
Officer. Mr. Green was the former Chief Financial Officer of GTC
Biotherapeutics and has held multiple senior finance roles in public and
private biotechnology companies over the course of his career.
... |
|  | | 05/09/13 | Verastem Reports First Quarter 2013 Financial and Corporate Results| CAMBRIDGE, Mass.--(BUSINESS WIRE)--May. 9, 2013--
Verastem, Inc., (NASDAQ: VSTM) focused on discovering and developing
drugs to treat cancer by the targeted killing of cancer stem cells,
today reported financial results for the quarter ended March 31, 2013,
and also commented on certain corporate accomplishments and plans.
“During the first quarter we made key strides in advancing our
development programs targeting cancer stem cells,” said Christ... |
|  | | 05/08/13 | Verastem to Present at Upcoming Conferences| CAMBRIDGE, Mass.--(BUSINESS WIRE)--May. 8, 2013--
Verastem, Inc., (NASDAQ: VSTM) focused on discovering and developing
drugs to treat cancer by the targeted killing of cancer stem cells,
announced that members of the management team will be presenting at
several upcoming conferences. The presentation details are as follows:
UBS Global Healthcare Conference on May 22, 2013, at 8:30am ET at the
Sheraton New York Hotel in New York, NY
... |
|  | | 04/17/13 | Verastem to Present at Upcoming Conferences| CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr. 17, 2013--
Verastem, Inc., (NASDAQ: VSTM) focused on discovering and developing
drugs to treat cancer by the targeted killing of cancer stem cells,
announced that members of the management team will be presenting at
several upcoming conferences. The presentation details are as follows:
2013 BIO International Convention Business Forum on April 22, 2013, at
2:15pm CT in the Chicago Bears room of M... |
|  |
|